Revenue
209 million USD
2025 Q2 · USD
Exact inputs and evidence
- Revenue: 209082000 USD Source
Annual consolidated revenue for 2024: about USD 936.7M, using the latest reported figures. The previous period, 2023, was about USD 1.161B.
209 million USD
2025 Q2 · USD
6.82%
2025 Q2 · %
-2.83 million USD
2025 Q2 · USD
-4.45 million USD
2025 Q2 · USD
131618000 USD
197350000 USD
9024240 shares
9.00% · 745 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
890 million USD
2024-07-01 – 2025-06-30
-69.9 million USD
2024-07-01 – 2025-06-30
4.11 million USD
2024-07-01 – 2025-06-30
-74.1 million USD
2024-07-01 – 2025-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-08-07.
Financial data available through: 2024-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 1.16 billion
–
Current period
USD 936.66 million
–
936657000 − 1160802000 = -224145000 USD
1160802000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source936657000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.15 billion
–
Current period
−USD 134.68 million
–
-134680000 − -1151454000 = 1016774000 USD
-1151454000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-134680000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 2.73 billion
–
Current period
−USD 123.22 million
–
-123217000 − -2726546000 = 2603329000 USD
-2726546000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-123217000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.9 million
–
Current period
USD 2.33 million
–
2333000 − 2897000 = -564000 USD
2897000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source2333000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | 280673000 | 406010000 Derived | -125337000 | 0 Derived | -125337000 | -9001000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 514887000 | 685270000 Derived | -170383000 | 78059000 Derived | -248442000 | -63712000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 1513033000 | 1856660000 Derived | -343627000 | 841235000 Derived | -1184862000 | 51645000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 751163000 | 1119919000 Derived | -368756000 | 1086788000 Derived | -1455544000 | 207018000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 1160802000 | 1737798000 Derived | -576996000 | 574458000 Derived | -1151454000 | -2729443000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 936657000 | 1044067000 Derived | -107410000 | 27270000 Derived | -134680000 | -125550000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 280673000 |
|
| 2020 | Revenue | 514887000 |
|
| 2021 | Revenue | 1513033000 |
|
| 2022 | Revenue | 751163000 |
|
| 2023 | Revenue | 1160802000 |
|
| 2024 | Revenue | 936657000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | 83.4% |
|
| 2021 | Year over year | 193.9% |
|
| 2022 | Year over year | -50.4% |
|
| 2023 | Year over year | 54.5% |
|
| 2024 | Year over year | -19.3% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Operating margin | -44.7% |
|
| 2020 | Operating margin | -33.1% |
|
| 2021 | Operating margin | -22.7% |
|
| 2022 | Operating margin | -49.1% |
|
| 2023 | Operating margin | -49.7% |
|
| 2024 | Operating margin | -11.5% |
|
| 2019 | Net margin | -44.7% |
|
| 2020 | Net margin | -48.3% |
|
| 2021 | Net margin | -78.3% |
|
| 2022 | Net margin | -193.8% |
|
| 2023 | Net margin | -99.2% |
|
| 2024 | Net margin | -14.4% |
|
| 2019 | Free cash flow margin | -3.2% |
|
| 2020 | Free cash flow margin | -12.4% |
|
| 2021 | Free cash flow margin | 3.4% |
|
| 2022 | Free cash flow margin | 27.6% |
|
| 2023 | Free cash flow margin | -235.1% |
|
| 2024 | Free cash flow margin | -13.4% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -8208000 |
|
| 2020 | Operating cash flow | -57238000 |
|
| 2021 | Operating cash flow | 82059000 |
|
| 2022 | Operating cash flow | 234466000 |
|
| 2023 | Operating cash flow | -2726546000 |
|
| 2024 | Operating cash flow | -123217000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | -9001000 |
|
| 2020 | Free cash flow | -63712000 |
|
| 2021 | Free cash flow | 51645000 |
|
| 2022 | Free cash flow | 207018000 |
|
| 2023 | Free cash flow | -2729443000 |
|
| 2024 | Free cash flow | -125550000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2020 | Liabilities / assets | 32.8% |
|
| 2021 | Liabilities / assets | 64.6% |
|
| 2022 | Liabilities / assets | 79.9% |
|
| 2023 | Liabilities / assets | 120.8% |
|
| 2024 | Liabilities / assets | 170.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2020 | Current assets / current liabilities | 2.09× |
|
| 2021 | Current assets / current liabilities | 0.73× |
|
| 2022 | Current assets / current liabilities | 0.97× |
|
| 2023 | Current assets / current liabilities | 0.78× |
|
| 2024 | Current assets / current liabilities | 0.61× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | −USD 125.34 million Exact valueExact value: -125337000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.21 million Exact valueExact value: -8208000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 793,000 Exact valueExact value: 793000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9 million Calculation and evidence-8208000 − 793000 USD Exact free cash flow: -9001000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 248.44 million Exact valueExact value: -248442000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 57.24 million Exact valueExact value: -57238000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.47 million Exact valueExact value: 6474000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.71 million Calculation and evidence-57238000 − 6474000 USD Exact free cash flow: -63712000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 1.18 billion Exact valueExact value: -1184862000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 82.06 million Exact valueExact value: 82059000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 30.41 million Exact valueExact value: 30414000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 51.65 million Calculation and evidence82059000 − 30414000 USD Exact free cash flow: 51645000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 1.46 billion Exact valueExact value: -1455544000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 234.47 million Exact valueExact value: 234466000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 27.45 million Exact valueExact value: 27448000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 207.02 million Calculation and evidence234466000 − 27448000 USD Exact free cash flow: 207018000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 1.15 billion Exact valueExact value: -1151454000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.73 billion Exact valueExact value: -2726546000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.9 million Exact valueExact value: 2897000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.73 billion Calculation and evidence-2726546000 − 2897000 USD Exact free cash flow: -2729443000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 134.68 million Exact valueExact value: -134680000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 123.22 million Exact valueExact value: -123217000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.33 million Exact valueExact value: 2333000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 125.55 million Calculation and evidence-123217000 − 2333000 USD Exact free cash flow: -125550000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
20 filings · 3,129 latest values · 3,113 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001671284, 1671284, BHG, NEUE, edgar:1671284
Also known as BRIGHT HEALTH GROUP, INC., Bright Health Group Inc., Bright Health Group, Inc., Bright Health Inc., NEUEHEALTH, INC., NeueHealth, Inc.